Millennium Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$918K Sell
3,294
-18,912
-85% -$5.45M ﹤0.01% 4449
2025
Q4
$6.73M Sell
22,206
-2,249
-9% -$702K ﹤0.01% 2689
2025
Q3
$6.86M Sell
24,455
-227,393
-90% -$61.9M 0.01% 2783
2025
Q2
$60.8M Sell
251,848
-84,204
-25% -$19.9M 0.05% 688
2025
Q1
$81.8M Sell
336,052
-43,025
-11% -$12.9M 0.08% 463
2024
Q4
$125M Sell
379,077
-204,723
-35% -$69.5M 0.11% 311
2024
Q3
$195M Buy
583,800
+575,643
+7,057% +$183M 0.17% 174
2024
Q2
$2.23M Sell
8,157
-14,754
-64% -$4.29M ﹤0.01% 3454
2024
Q1
$7.92M Sell
22,911
-200,331
-90% -$65.9M 0.01% 2414
2023
Q4
$72.1M Sell
223,242
-153,377
-41% -$48.1M 0.07% 579
2023
Q3
$135M Buy
376,619
+120,055
+47% +$46.3M 0.14% 249
2023
Q2
$97.3M Sell
256,564
-200,716
-44% -$81.7M 0.1% 375
2023
Q1
$219M Buy
457,280
+142,199
+45% +$66.6M 0.25% 102
2022
Q4
$132M Sell
315,081
-143,564
-31% -$57.9M 0.15% 270
2022
Q3
$191M Buy
458,645
+79,316
+21% +$39.5M 0.24% 114
2022
Q2
$188M Buy
379,329
+89,424
+31% +$46.6M 0.24% 99
2022
Q1
$163M Buy
289,905
+261,317
+914% +$158M 0.2% 166
2021
Q4
$21.6M Sell
28,588
-139,654
-83% -$105M 0.02% 1372
2021
Q3
$126M Buy
168,242
+43,809
+35% +$32.8M 0.17% 236
2021
Q2
$80.2M Sell
124,433
-70,936
-36% -$43.2M 0.1% 395
2021
Q1
$112M Buy
195,369
+54,670
+39% +$32.4M 0.16% 203
2020
Q4
$82M Sell
140,699
-26,671
-16% -$15.2M 0.11% 272
2020
Q3
$86.3K Sell
167,370
-10,722
-6% -$5.43M 0.2% 155
2020
Q2
$80.4M Buy
178,092
+56,469
+46% +$24.9M 0.19% 151
2020
Q1
$42.6M Sell
121,623
-147,356
-55% -$54.2M 0.17% 193
2019
Q4
$99.5M Sell
268,979
-202,382
-43% -$71.3M 0.18% 149
2019
Q3
$157M Sell
471,361
-54,563
-10% -$17.8M 0.33% 52
2019
Q2
$164M Buy
525,924
+105,050
+25% +$31.5M 0.31% 53
2019
Q1
$129M Buy
420,874
+22,546
+6% +$6.08M 0.23% 89
2018
Q4
$92.5M Buy
398,328
+20,503
+5% +$5.5M 0.16% 164
2018
Q3
$118M Sell
377,825
-191,918
-34% -$59.6M 0.16% 149
2018
Q2
$164M Buy
569,743
+294,523
+107% +$81.3M 0.23% 74
2018
Q1
$68.8M Buy
275,220
+95,218
+53% +$24.2M 0.1% 300
2017
Q4
$43M Buy
180,002
+95,235
+112% +$23.1M 0.06% 486
2017
Q3
$18.8M Buy
84,767
+76,017
+869% +$17.1M 0.03% 830
2017
Q2
$1.98M Sell
8,750
-282,654
-97% -$61.6M ﹤0.01% 2078
2017
Q1
$58.1M Sell
291,404
-67,219
-19% -$12.9M 0.11% 270
2016
Q4
$65.4M Buy
358,623
+25,438
+8% +$4.34M 0.14% 187
2016
Q3
$54.6M Buy
333,185
+61,670
+23% +$9.36M 0.1% 228
2016
Q2
$38.8M Sell
271,515
-47,039
-15% -$6.71M 0.1% 279
2016
Q1
$43.6M Buy
318,554
+79,129
+33% +$10.4M 0.12% 213
2015
Q4
$33.2M Sell
239,425
-207,237
-46% -$28.7M 0.08% 387
2015
Q3
$60M Buy
446,662
+180,541
+68% +$26M 0.13% 190
2015
Q2
$40.1M Sell
266,121
-31,803
-11% -$4.55M 0.08% 332
2015
Q1
$40.3M Buy
297,924
+198,385
+199% +$24.6M 0.08% 337
2014
Q4
$12M Sell
99,539
-8,684
-8% -$999K 0.03% 883
2014
Q3
$12.3M Sell
108,223
-58,806
-35% -$6.97M 0.03% 757
2014
Q2
$20M Buy
167,029
+4,987
+3% +$609K 0.06% 482
2014
Q1
$20.8M Buy
162,042
+56,355
+53% +$7.22M 0.07% 430
2013
Q4
$13.1M Buy
105,687
+72,043
+214% +$8.78M 0.05% 540
2013
Q3
$3.96M Sell
33,644
-16,936
-33% -$2M 0.02% 1251
2013
Q2
$5.67M Buy
+50,580
New +$5.93M 0.03% 934

Other funds holding BIO